Drug Type Small molecule drug |
Synonyms- |
Action inhibitors |
Mechanism EZH2 inhibitors(Histone-lysine N-methyltransferase EZH2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseDiscovery |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiovascular Diseases | Discovery | - | 16 Aug 2024 | |
Congenital Abnormalities | Discovery | - | 16 Aug 2024 | |
Digestive System Disorders | Discovery | - | 16 Aug 2024 | |
Immune System Diseases | Discovery | - | 16 Aug 2024 | |
Neoplasms | Discovery | - | 16 Aug 2024 | |
Nervous System Diseases | Discovery | - | 16 Aug 2024 | |
Other Diseases | Discovery | - | 16 Aug 2024 | |
Pulpitis | Discovery | - | 16 Aug 2024 | |
Respiratory Diseases | Discovery | - | 16 Aug 2024 | |
Thyroiditis | Discovery | - | 16 Aug 2024 |